Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage atm kinase'

Search results for: 'research area dna damage atm kinase'

Items 131-140 of 274

Page
per page
  1. OTSSP167
    B1321 OTSSP167
    Target: MELK
    Summary: MELK inhibitor
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  2. LY2109761
    A8464 LY2109761
     4 Citation
    Summary: TβRI/II kinase inhibitor
      ≥22.1 mg/mL
  3. GW2580
    A1655 GW2580
     1 Citation
    Target: CSF-1R
    Summary: CFMS kinase/CSF-1R inhibitor,selective and ATP-competitive
      ≥36.6 mg/mL
  4. AKT inhibitor VIII
    A3149 AKT inhibitor VIII
     2 Citation
    Target: Akt
    Summary: Allosteric Akt kinase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.2 mg/mL
  5. PD173955
    A8812 PD173955
    Target: Bcr-Abl|Src
    Summary: Dual Src/Abl kinase inhibitor, ATP-competitive,
      ≥22.15 mg/mL
  6. AMG 925
    B3277 AMG 925
    Target: Cyclin-Dependent Kinases|FLT3
    Summary: FLT3/CDK4 inhibitor,potent and selective
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  7. Sotrastaurin (AEB071)
    A8525 Sotrastaurin (AEB071)
    Target: PKC
    Summary: PKC inhibitor
      ≥21.9 mg/mL
  8. ML167
    B3707 ML167
    Target: Clk
    Summary: Clk4 inhibitor,highly selective
      insoluble in EtOH; insoluble in H2O; ≥16.75 mg/mL
  9. Torin 2
    B1640 Torin 2
     1 Citation
    Target: mTOR|DNA-PK|ATM/ATR
    Summary: MTOR inhibitor,highly potent and selective
      ≥21.6 mg/mL
  10. GF 109203X
    A8342 GF 109203X
     1 Citation
    Target: PKC
    Summary: Protein kinase C,MLCK,PKG and PKA inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.6 mg/mL

Items 131-140 of 274

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 1 item
  2. Apoptosis 5item
  3. Chromatin/Epigenetics 28item
  4. Metabolism 1 item
  5. MAPK Signaling 20item
  6. Tyrosine Kinase 85item
  7. DNA Damage/DNA Repair 25item
  8. PI3K/Akt/mTOR Signaling 38item
  9. Microbiology & Virology 2item
  10. Cell Cycle/Checkpoint 54item
  11. Ubiquitination/ Proteasome 3item
  12. JAK/STAT Signaling 23item
  13. TGF-β / Smad Signaling 26item
  14. Angiogenesis 1 item
  15. GPCR/G protein 3item
  16. Stem Cell 6item
  17. Membrane Transporter/Ion Channel 3item
  18. Others 17item
  19. Immunology/Inflammation 2item
Reversibility
  1. Reversible 21item
  2. Irreversible 5item
Target
  1. Cyclin-Dependent Kinases 21item
  2. Akt 2item
  3. PI3K 14item
  4. Raf 7item
  5. Aurora Kinases 13item
  6. CSF-1R 2item
  7. mTOR 8item
  8. AP-1 1 item
  9. FLT3 8item
  10. GSK-3 7item
  11. PLK 4item
  12. Chk 5item
  13. Eph Receptors 3item
  14. VEGFR 19item
  15. PDGFR 14item
  16. c-Kit 6item
  17. RET 3item
  18. IRAK 2item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. Thymidylate Synthase 1 item
  21. p38 6item
  22. PKB 1 item
  23. JNK 2item
  24. SGK 2item
  25. Bcr-Abl 10item
  26. MEK 4item
  27. FGFR 6item
  28. Pim 4item
  29. Ribosomal s6 kinases (RSK) 1 item
  30. MET 5item
  31. Src 8item
  32. Trk Receptors 2item
  33. STAT 3item
  34. EGFR 10item
  35. ROCK 6item
  36. BTK 1 item
  37. PAK 3item
  38. FAK 4item
  39. BMP and Other Activin Receptors 2item
  40. JAK 9item
  41. Syk 5item
  42. DNA-PK 6item
  43. AMPK 2item
  44. PDHK 1 item
  45. Topoisomerases 5item
  46. ErbB 2item
  47. S6 kinases 1 item
  48. Adenosine Kinases 2item
  49. DNA Methyltransferases 3item
  50. ERK 2item
  51. c-MET 5item
  52. PKC 5item
  53. Ubiquitin-specific proteases 1 item
  54. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  55. Lyn 1 item
  56. HER2 2item
  57. Pyk2 3item
  58. LRRK2 3item
  59. Insulin and Insulin-like Receptors 2item
  60. ALK 3item
  61. ROS1 1 item
  62. Sphingosine kinases (SphKs) 1 item
  63. PKG 1 item
  64. PKA 1 item
  65. Myosin light chain kinases (MLCKs) 2item
  66. CaM-KK 1 item
  67. MELK 1 item
  68. Insulin-like growth factors (IGFs) 1 item
  69. Clk 1 item
  70. NUAK1 1 item
  71. NUAK2 1 item
  72. MK2 2item
  73. Fatty-acid-binding proteins (FABPs) 1 item
  74. Tie-2 2item
  75. RSK 1 item
  76. ATM/ATR 4item
  77. CK1 1 item
  78. Farnesyl Diphosphate Synthases 1 item
  79. CK2 3item
  80. HIPK2 1 item
  81. HIPK3 1 item
  82. P2X Receptors 1 item
  83. BLM 1 item
  84. HSV 1 item
  85. Synthases/Synthetases 2item
  86. MAGL 1 item
  87. c-Fyn 1 item
  88. TAK1 1 item
  89. P110 1 item
  90. Hck 1 item
  91. RNA Polymerases 1 item
  92. Insulin Receptors 1 item
  93. IRG-1R 1 item
  94. eEF-2 1 item
  95. Cdc7 1 item
  96. CMV 1 item
  97. ZAP-70 1 item
  98. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  99. Cytidine deaminases 1 item
  100. c-RET 1 item
  101. p70 rsk 1 item
  102. TAM kinase 1 item
  103. AXL 1 item
  104. c-Fms tyrosine kinase 1 item
  105. STK 1 item
  106. MSK 1 item
  107. Lyn kinase 1 item
  108. ITK 1 item
  109. NUAK 1 item
  110. DCLK2 1 item
  111. Lck 1 item
  112. PKD 1 item
  113. tropomyosin receptor kinase 1 item
  114. SK 1 item
  115. ATM 2item
  116. Sirtuin 1 item
  117. PIKfyve 1 item
  118. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 240item
  2. Cell Experiments 150item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 16item
  3. Acute Renal Failure 1 item
  4. Adrenocortical Carcinoma 2item
  5. Advanced Renal Cell Carcinoma 1 item
  6. Bladder Cancer 5item
  7. Bladder Carcinoma 2item
  8. Bladder Diseases 1 item
  9. B-lymphoid Malignancies 1 item
  10. Breast Cancer 49item
  11. Cancer 182item
  12. Cervical Cancer 5item
  13. Cholangiocarcinoma 2item
  14. Chronic Lymphocytic Leukemia 2item
  15. Clear Cell Renal Cell Carcinoma 1 item
  16. Colon Cancer 24item
  17. Colon Carcinoma 2item
  18. Colorectal Cancer 22item
  19. Glioblastoma 18item
  20. Glioma 6item
  21. Hepatocellular Carcinoma 5item
  22. HIV Infections 2item
  23. Immunological Diseases 1 item
  24. Inflammatory Bowel Disease 1 item
  25. Inflammatory Diseases 5item
  26. Leukemia 10item
  27. Liver Cancer 3item
  28. Lung Cancer 17item
  29. Lung Carcinoma 3item
  30. Lymphoma 11item
  31. Mantle Cell Lymphoma 1 item
  32. Melanoma 15item
  33. Multiple Myeloma 7item
  34. Myelofibrosis 1 item
  35. Myeloma 2item
  36. Neuroblastoma 3item
  37. Non-small Cell Lung Cancer 5item
  38. Non-small Cell Lung Carcinoma 1 item
  39. Ovarian Cancer 19item
  40. Pancreatic Cancer 24item
  41. Prostate Cancer 21item
  42. Psoriasis 1 item
  43. Pulmonary Arterial Hypertension 1 item
  44. Renal Cancer 3item
  45. Renal Cell Carcinoma 5item
  46. Rheumatoid Arthritis 5item
  47. Sarcoma 1 item
  48. Squamous Cell Carcinoma 1 item
  49. Testicular Cancer 2item
  50. Thyroid Cancer 5item
  51. Type 2 Diabetes 3item